Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction

Sundra, T. Kelty, E. Rossi, G. Rendle, D. 2024 Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction

Front. Vet. Sci., 06 March 2024 Sec. Veterinary Pharmacology and Toxicology
Volume 11 – 2024 | https://doi.org/10.3389/fvets.2024.1332337

Frontiers | Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction (frontiersin.org)

Hyperinsulinemia-Associated Laminitis (HAL), a focus on the foot (2025)

Join Dr Andy Fiske-Jackson for an in-depth webinar on Hyperinsulinemia-Associated Laminitis (HAL)…

Equine Metabolic Syndrome Management (2025)

Learn how to manage Equine Metabolic Syndrome in 2025 with diet, exercise, and emerging treatments…

Testing for EMS, who, why, when, how? (2025)

This session will outline the various diagnostic protocols available for assessing Equine Metabolic…
Load More